TCT 2024 — Join interventional cardiologists, Prof Nicolas Van Mieghem and Dr Joost Daemen from the Thoraxcenter as they unpack the most impactful late-breaking clinical trials and science data from this year's Transcatheter Cardiovascular Therapeutics Conference.

Dive into this practical and engaging discussion and learn more about the latest data for practice and for research.

Trials covered in detail include:

ECLIPSE (00:49 - 05:55)
FAVOR III (05:55 - 10:30)
FLASH (10:30 - 12:54)
DCB BIFURCATION (12:54 - 15:17)
EARLY TAVR (15:17 - 21:14)
EVOLVED (21:14 - 24:07)
TAVR-UNLOAD (24:07 - 28:57)
PEERLESS (28:57 - 31:14)
CLEAR IE (31:14 - 33:29)
TRISCEND II (33:29 - 36:36)
ACCESS TAVI (36:36 - 40:05)
ALIGN AR (40:05 - 41:49)
COSTAR RCT (41:49 - 43:36)
ACURATE IDE (43:36 - 46:42)
CLEAR SYNERGY(46:42 - 48:41)

Support: This is an independent interview produced by Radcliffe Cardiology.